Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) Gross Margin (2025 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Gross Margin of -47.68% in Q2 2026, down 67.96 percentage points from the prior quarter.

Analysis

Aspire-Lakewood Holdings (ASBP) Gross Margin (2025 - 2026) Analysis & Trends

On a TTM basis, Aspire Biopharma Holdings' Gross Margin came in at -25.04% as of Jun 30, 2026; for FY2025, it came in at -1.87%.

  • Per Business Quant, the preceding three quarters came in at 20.28% (Q1 2026), -23.47% (Q4 2025) and 45.54% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 -47.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47.68%
Mar 31, 2026 20.28%
Dec 31, 2025 -23.47%
Sep 30, 2025 45.54%
API Access

Aspire-Lakewood Holdings Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEY